Warning: The NCBI web site requires JavaScript to function. more...
Nonsteroidal Anti-Inflammatory Drugs: A survey of practices and concerns of pediatric medical and surgical specialists and a summary of available safety data.
Levy DM, Imundo LF.
Pediatr Rheumatol Online J. 2010 Feb 4;8:7.
Related citations
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation.
Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, Taylor RS.
Health Technol Assess. 2008 Apr;12(11):1-278, iii. Review.
Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers.
Elnachef N, Scheiman JM, Fendrick AM, Howden CW, Chey WD.
Aliment Pharmacol Ther. 2008 Nov 15;28(10):1249-58. Epub 2008 Aug 22.
Withdrawal of COX-2 selective inhibitors rofecoxib and valdecoxib: impact on NSAID and gastroprotective drug prescribing and utilization.
Sun SX, Lee KY, Bertram CT, Goldstein JL.
Curr Med Res Opin. 2007 Aug;23(8):1859-66.
A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines.
Price-Forbes AN, Callaghan R, Allen ME, Rowe IF.
Rheumatology (Oxford). 2005 Jul;44(7):921-4. Epub 2005 Apr 12.
Risks versus benefits of cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs.
Chaiamnuay S, Allison JJ, Curtis JR.
Am J Health Syst Pharm. 2006 Oct 1;63(19):1837-51. Review.
Prescription of nonsteroidal anti-inflammatory drugs and muscle relaxants for back pain in the United States.
Luo X, Pietrobon R, Curtis LH, Hey LA.
Spine (Phila Pa 1976). 2004 Dec 1;29(23):E531-7.
COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery.
Cicconetti A, Bartoli A, Ripari F, Ripari A.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Feb;97(2):139-46.
Selective cyclooxygenase-2 inhibitors for the treatment of arthritis.
Fung HB, Kirschenbaum HL.
Clin Ther. 1999 Jul;21(7):1131-57. Review.
"Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs.
Bennett K, Teeling M, Feely J.
Eur J Clin Pharmacol. 2003 Nov;59(8-9):645-9. Epub 2003 Aug 27.
Incremental cost-effectiveness of cyclooxygenase 2-selective versus nonselective nonsteroidal anti-inflammatory drugs in a cohort of coumarin users: a pharmacoeconomic analysis linked to a case-control study.
Knijff-Dutmer EA, Postma MJ, van der Palen J, Brouwers JR, van de Laar MA.
Clin Ther. 2004 Jul;26(7):1160-7.
Concomitant use of gastroprotective drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study.
Johnell K, Fastbom J.
Clin Drug Investig. 2008;28(11):687-95.
Nonsteroidal anti-inflammatory drugs for low back pain: an updated Cochrane review.
Roelofs PD, Deyo RA, Koes BW, Scholten RJ, van Tulder MW.
Spine (Phila Pa 1976). 2008 Jul 15;33(16):1766-74. Review.
A comparison of the cost-effectiveness of five strategies for the prevention of non-steroidal anti-inflammatory drug-induced gastrointestinal toxicity: a systematic review with economic modelling.
Brown TJ, Hooper L, Elliott RA, Payne K, Webb R, Roberts C, Rostom A, Symmons D.
Health Technol Assess. 2006 Oct;10(38):iii-iv, xi-xiii, 1-183. Review.
Analgesic prescribing for musculoskeletal complaints in the ambulatory care setting after the introduction and withdrawal of cyclooxygenase-2 inhibitors.
Wilson RD.
Arch Phys Med Rehabil. 2009 Jul;90(7):1147-51.
Understanding NSAIDs: from aspirin to COX-2.
Green GA.
Clin Cornerstone. 2001;3(5):50-60. Review.
Valdecoxib: a review.
Chavez ML, DeKorte CJ.
Clin Ther. 2003 Mar;25(3):817-51. Review.
Pediatrician and family physician prescription of selective serotonin reuptake inhibitors.
Rushton JL, Clark SJ, Freed GL.
Pediatrics. 2000 Jun;105(6):E82.
Cyclo-oxygenase-2 inhibitors: when should they be used in the elderly?
Savage R.
Drugs Aging. 2005;22(3):185-200. Review.
The prevalence of cardiorenal risk factors in patients prescribed nonsteroidal anti-inflammatory drugs: data from managed care.
Harley C, Wagner S.
Clin Ther. 2003 Jan;25(1):139-49.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on